Mohammed F Islam, MD
Alt:
(724) 657-6833
Fax: (724) 657-6799
Fax: (724) 657-6799
3124 Wilmington Road,, Suite 203, New Castle, Pennsylvania, 16105
Business hours
| Monday | 10:00am to 4:00pm |
| Tuesday | 10:00am to 4:00pm |
| Wednesday | 10:00am to 4:00pm |
| Thursday | 10:00am to 4:00pm |
| Friday | 10:00am to 4:00pm |
| Saturday | - |
| Sunday | - |
About us
Call today!
| Languages | Bengali, Urdu, Persian (Farsi), Hindi, Arabic, English |
| Services | lymphedema physical therapy, chemotherapy iv infusion, rectal neuroendocrine tumor, neuroendocrine carcinoma, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, upper extremity lymphedema, large cell neuroendocrine tumors, metastatic blood cancers, neuroendocrine tumor of the lung, generalized lymphatic anomaly, adenocarcinoma of the bladder, hormone receptor negative breast cancer, fibrolamellar carcinoma, ductal carcinoma in situ (dcis), personal history of cancer, secondary cancer screening, long term side effects of cancer treatment, personal history of radiation therapy, personal history of chemotherapy, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), breast cancer biological targeted therapy, relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, hormone receptor positive breast cancer, her2 positive breast cancer, carcinoma of unknown primary, lymphomatoid granulomatosis, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, er negative breast cancer, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, inflammatory breast cancer, recurrent breast cancer, brain metastases, coagulation disorders, bone marrow failure syndromes, waldenstrom macroglobulinemia, primary myelofibrosis, oral complications of cancer, non hodgkin lymphoma, myeloproliferative diseases, lymphoid leukemia, lymphedema therapy, large granular lymphocytic leukemia, hematologic malignancies, head and neck cancer, cancer related fatigue, hereditary cancer risk, bone marrow disorders, blood cancer, anaplastic large cell lymphoma, adverse effects to anticoagulants, adult t cell leukemia, head and neck tumors, reduced intensity conditioning regimens, lymphoblastic lymphoma, germinoma, fanconi anemia, epithelioid hemangioendothelioma, diamond blackfan anemia, bladder cancer, cancer screening, thyroid cancer, thrombotic thrombocytopenic purpura, thrombophilia, thrombocytopenia, thalassemia, stomach cancer, splenomegaly, small cell lung cancer, secondary polycythemia, sarcoma, rhabdomyosarcoma |